Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy

NCT07056010 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

PROCEDURE: curative minimally invasive gastrectomy with D2+PAND lymphadenectomy

Sponsor

The First Affiliated Hospital with Nanjing Medical University